» Authors » Dirk Lehnick

Dirk Lehnick

Explore the profile of Dirk Lehnick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 302
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneider U, Bohlhalter S, Wuthrich F, Lehnick D, von Hessling A
Swiss Med Wkly . 2025 Jan; 154():3727. PMID: 39835743
The choice of modality of treatment for unruptured intracranial aneurysms is based on various clinical aspects and the patient's preference. Financial considerations should not be among these. To evaluate any...
2.
Furrer-Matcau C, Sieber C, Lehnick D, Brand C, Hug B
Front Oncol . 2024 Dec; 14:1485594. PMID: 39703836
Introduction: Checkpoint inhibitors are increasingly important in anti-cancer treatment. Therefore, knowledge of immune-related cutaneous adverse events (ir-cAE) is crucial for therapy management and continuation. Objective: The study aimed to analyze...
3.
Hertig-Godeschalk A, Sailer C, Perret C, Lehnick D, Scheel-Sailer A, Flueck J
Top Spinal Cord Inj Rehabil . 2024 Dec; 30(4):24-34. PMID: 39619824
Background: Insufficient 25-hydroxyvitamin D [25(OH)D] levels are associated with falls, fractures, and worse overall health outcomes. We evaluated 25(OH)D levels in individuals with spinal cord injury or disorder (SCI/D) during...
4.
Vollenweider N, Poblete B, Babst R, Beeres F, Lehnick D, Link B
BMC Geriatr . 2024 Nov; 24(1):959. PMID: 39558199
Background: Hip fractures in older adults are common and carry a high risk of morbidity and mortality. Preoperative dehydration, a key risk factor for adverse outcomes, is often underdiagnosed at...
5.
Dimopoulou V, Klingenberg C, Naver L, Nordberg V, Berardi A, El Helou S, et al.
Pediatr Res . 2024 Sep; PMID: 39289592
Background: Early-life antibiotic exposure is disproportionately high compared to the burden of culture-proven early-onset sepsis (CP-EOS). We assessed the contribution of culture-negative cases to the overall antibiotic exposure in the...
6.
Ulrich M, Lehnick D, Strobel K, Grunig H, Lima T, Iselin L, et al.
Nucl Med Commun . 2024 Jul; 45(10):848-857. PMID: 39011813
Purpose: The purpose of this study was to evaluate and quantify the prevalence of increased uptake in SPECT/CT in symptomatic and asymptomatic foot and ankle joints in patients with osteoarthritis....
7.
Schlapfer N, Papp L, Lehnick D, Harder M, Simmen D, Linder T
J Laryngol Otol . 2024 May; 138(10):1024-1029. PMID: 38751234
Objective: This retrospective study aimed to establish a robust rating system for assessing post-operative outcomes in congenital aural atresia patients undergoing auricular reconstruction. The newly introduced EAR scale, a weighted...
8.
Wessels H, von Richter O, Velinova M, Hofler J, Chamberlain P, Kromminga A, et al.
Expert Opin Biol Ther . 2023 Dec; 23(12):1287-1297. PMID: 38044885
Background: PB006 (Polpharma Biologics S.A; marketed as Tyruko®, Sandoz) is an approved biosimilar to natalizumab (Tysabri®; Biogen [ref-NTZ]). This multicenter, double-blind, randomized, single-dose study was conducted to demonstrate pharmacokinetic/pharmacodynamic (PK/PD)...
9.
Bhure U, Cieciera M, Lehnick D, Perez Lago M, Grunig H, Lima T, et al.
Eur J Hybrid Imaging . 2023 Sep; 7(1):17. PMID: 37718372
Objective: To evaluate the detection rate and performance of 18F-FDG PET alone (PET), the combination of PET and low-dose thick-slice CT (PET/lCT), PET and diagnostic thin-slice CT (PET/dCT), and additional...
10.
Bhure U, Grunig H, Perez Lago M, Lehnick D, Wonerow M, Lima T, et al.
Eur J Nucl Med Mol Imaging . 2023 Sep; 51(1):68-80. PMID: 37676502
Objective: To evaluate the value of SPECT/CT (single photon emission computed tomography/computed tomography) in foot and ankle arthrodesis and development of secondary osteoarthritis in the adjacent joints. Materials And Methods:...